E10. In Conversation with Endometriosis Expert A/Prof Mathew Leonardi (video) Video
Talking O&G - a RANZCOG PodcastShow Notes
In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis. An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology. During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility. 🔗 Resources mentioned in this episode:
Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline Australian Living Evidence Guideline: Endometriosis Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/
📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.
More from Talking O&G - a RANZCOG Podcast
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks to gynaecologist Dr Catriona Melville and general practitioner Dr Anita Muñoz about RANZCOG’s binational clinical guideline Management of Vasomotor and Genitourinary Symptoms of Menopause. Dr Melville and Dr Muñoz speak on the scope of the guideline and how it can be used to support clinicians in assessment and treatment of vasomotor and genitourinary symptoms during menopause. They unpack the range of recommendations in the guideline, including menopausal hormone therapy (MHT) and non-hormonal therapies, and considerations such as when to begin and cease treatment, and treating women with a history of breast cancer. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks to gynaecologist Dr Catriona Melville and general practitioner Dr Anita Muñoz about RANZCOG’s binational clinical guideline Management of Vasomotor and Genitourinary Symptoms of Menopause. Dr Melville and Dr Muñoz speak on the scope of the guideline and how it can be used to support clinicians in assessment and treatment of vasomotor and genitourinary symptoms during menopause. They unpack the range of recommendations in the guideline, including menopausal hormone therapy (MHT) and non-hormonal therapies, and considerations such as when to begin and cease treatment, and treating women with a history of breast cancer. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Lucy Bowyer about the SOMANZ guidelines for the investigation and management of sepsis in pregnancy. Despite the overall maternal mortality rate declining in Australia, rates of maternal sepsis remain stable, and it is one of the most common causes of maternal deaths reported by the Australian Institute of Health and Welfare. A/Prof White and Dr Bowyer examine the statistics and why they have not declined alongside the overall maternal mortality rate. They explore the recommendations in the SOMANZ guideline and how they can be used to improve sepsis detection and treatment. Dr Bowyer provides actionable advice for clinicians regarding considerations such as anaesthesia, fetal surveillance, and antibiotics while breastfeeding. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Lucy Bowyer about the SOMANZ guidelines for the investigation and management of sepsis in pregnancy. Despite the overall maternal mortality rate declining in Australia, rates of maternal sepsis remain stable, and it is one of the most common causes of maternal deaths reported by the Australian Institute of Health and Welfare. A/Prof White and Dr Bowyer examine the statistics and why they have not declined alongside the overall maternal mortality rate. They explore the recommendations in the SOMANZ guideline and how they can be used to improve sepsis detection and treatment. Dr Bowyer provides actionable advice for clinicians regarding considerations such as anaesthesia, fetal surveillance, and antibiotics while breastfeeding. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Rosie McBain, gynaecological oncologist, about cystic spaces in the endometrium on ultrasound and the correlation with endometrial hyperplasia or cancer. Dr McBain draws from the retrospective cohort study she conducted to examine this topic, the findings of which are published in ANZJOG. Dr Waterfall and Dr McBain discuss the findings of the study, its clinical implications, and areas that require further research. They address the nuances of clinical studies and the importance of patient-centred, individualised care. 🔗 Resources mentioned in this episode: